Literature DB >> 17940175

Non-infectious fever in the neurological intensive care unit: incidence, causes and predictors.

Alejandro A Rabinstein1, Kirsten Sandhu.   

Abstract

BACKGROUND AND
OBJECTIVE: Non-infectious causes of fever are often considered in critical neurological patients but their true significance has not been formally studied. The aim of this study was to evaluate the incidence, causes and predictors of fever in patients with acute neurological/neurosurgical disease and no documented infection.
METHODS: Prospective data collection of consecutive patients admitted to the neurological intensive care unit (NICU) of an academic medical centre for more than 48 h was carried out. Fever was defined as body temperature > or = 101 degrees F (38.3 degrees C) documented on at least one measurement for 2 consecutive days. Patients were enrolled only if a diagnostic workup, including cultures of > or = 2 body samples, was performed before antibiotic use. Febrile patients with no proven evidence of infection were considered to have non-infectious fever.
RESULTS: 93 patients were included in the final analysis. Fever was non-infectious in 31 patients (33%). There were no differences between the infectious and non-infectious fever groups in terms of age, use and duration of invasive catheters, daily duration of fever and number of days with fever. Documented infections tended to be more common among febrile patients with traumatic brain injury (52% vs 36%; p = 0.06). Non-infectious fever was more frequent among patients with subarachnoid haemorrhage (48% vs 18%; p = 0.01) in whom it was associated with vasospasm (p = 0.03) and symptomatic vasospasm (p = 0.05). Non-infectious fever started earlier (mean 2.6 vs 4 days; p = 0.007) and onset of fever within the first 72 h of admission predicted negative evaluation for infection (p = 0.01). Subarachnoid haemorrhage and fever onset within the first 72 h were independent predictors of non-infectious fever on multivariable analysis.
CONCLUSIONS: Fever in the absence of documented infections occurs commonly in the NICU, especially among patients with subarachnoid haemorrhage and vasospasm. Early onset of fever predicts a non-infectious cause.

Entities:  

Mesh:

Year:  2007        PMID: 17940175      PMCID: PMC2117587          DOI: 10.1136/jnnp.2006.112730

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  20 in total

1.  Pyrexia in head-injured patients admitted to intensive care.

Authors:  Nino Stocchetti; Sandra Rossi; Elisa Roncati Zanier; Angelo Colombo; Luigi Beretta; Giuseppe Citerio
Journal:  Intensive Care Med       Date:  2002-10-04       Impact factor: 17.440

2.  Risk factors for fever in the neurologic intensive care unit.

Authors:  Christopher Commichau; Nikolaos Scarmeas; Stephan A Mayer
Journal:  Neurology       Date:  2003-03-11       Impact factor: 9.910

3.  Achieving normothermia in patients with febrile subarachnoid hemorrhage: feasibility and safety of a novel intravascular cooling catheter.

Authors:  Neeraj Badjatia; Joan O'Donnell; John R Baker; David Huang; Cenk Ayata; David M Greer; Bob S Carter; Christopher S Ogilvy; Colin T McDonald
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

4.  Fever in subarachnoid hemorrhage: relationship to vasospasm and outcome.

Authors:  J Oliveira-Filho; M A Ezzeddine; A Z Segal; F S Buonanno; Y Chang; C S Ogilvy; G Rordorf; L H Schwamm; W J Koroshetz; C T McDonald
Journal:  Neurology       Date:  2001-05-22       Impact factor: 9.910

5.  Brain temperature, body core temperature, and intracranial pressure in acute cerebral damage.

Authors:  S Rossi; E R Zanier; I Mauri; A Columbo; N Stocchetti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-10       Impact factor: 10.154

6.  Incidence and prognostic significance of fever following intracerebral hemorrhage.

Authors:  S Schwarz; K Häfner; A Aschoff; S Schwab
Journal:  Neurology       Date:  2000-01-25       Impact factor: 9.910

7.  Hyperthermia in the neurosurgical intensive care unit.

Authors:  M M Kilpatrick; D W Lowry; A D Firlik; H Yonas; D W Marion
Journal:  Neurosurgery       Date:  2000-10       Impact factor: 4.654

8.  Induced hyperthermia exacerbates neurologic neuronal histologic damage after asphyxial cardiac arrest in rats.

Authors:  Robert W Hickey; Patrick M Kochanek; Howard Ferimer; Henry L Alexander; Robert H Garman; Steven H Graham
Journal:  Crit Care Med       Date:  2003-02       Impact factor: 7.598

9.  Elevated body temperature independently contributes to increased length of stay in neurologic intensive care unit patients.

Authors:  Michael N Diringer; Nancy L Reaven; Susan E Funk; Gwen C Uman
Journal:  Crit Care Med       Date:  2004-07       Impact factor: 7.598

Review 10.  Hyperthermia following traumatic brain injury: a critical evaluation.

Authors:  Hilaire J Thompson; Nancy C Tkacs; Kathryn E Saatman; Ramesh Raghupathi; Tracy K McIntosh
Journal:  Neurobiol Dis       Date:  2003-04       Impact factor: 5.996

View more
  26 in total

1.  Intensive care unit management of aneurysmal subarachnoid hemorrhage.

Authors:  Jennifer E Fugate; Alejandro A Rabinstein
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

Review 2.  Fever management in SAH.

Authors:  V Scaravilli; G Tinchero; G Citerio
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

3.  Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids with seizures and central pyrexia, in a patient requiring tracheal intubation and mechanical ventilation: A case report.

Authors:  Rosemary J Wall
Journal:  J Intensive Care Soc       Date:  2017-07-17

4.  Adult-onset Leigh syndrome with central fever and peripheral neuropathy due to mitochondrial 9176T>C mutation.

Authors:  Yanping Wei; Lin Wang
Journal:  Neurol Sci       Date:  2018-08-22       Impact factor: 3.307

5.  Refining the Association of Fever with Functional Outcome in Aneurysmal Subarachnoid Hemorrhage.

Authors:  Christopher L Kramer; Marianna Pegoli; Jay Mandrekar; Giuseppe Lanzino; Alejandro A Rabinstein
Journal:  Neurocrit Care       Date:  2017-02       Impact factor: 3.210

Review 6.  Autonomic dysfunction syndromes after acute brain injury.

Authors:  Courtney Takahashi; Holly E Hinson; Ian J Baguley
Journal:  Handb Clin Neurol       Date:  2015

7.  Procalcitonin is a Poor Predictor of Non-Infectious Fever in the Neurocritical Care Unit.

Authors:  Karin Halvorson; Sameer Shah; Corey Fehnel; Bradford Thompson; N Stevenson Potter; Mitchell Levy; Linda Wendell
Journal:  Neurocrit Care       Date:  2017-10       Impact factor: 3.210

Review 8.  Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference.

Authors:  Michael N Diringer; Thomas P Bleck; J Claude Hemphill; David Menon; Lori Shutter; Paul Vespa; Nicolas Bruder; E Sander Connolly; Giuseppe Citerio; Daryl Gress; Daniel Hänggi; Brian L Hoh; Giuseppe Lanzino; Peter Le Roux; Alejandro Rabinstein; Erich Schmutzhard; Nino Stocchetti; Jose I Suarez; Miriam Treggiari; Ming-Yuan Tseng; Mervyn D I Vergouwen; Stefan Wolf; Gregory Zipfel
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

9.  Genetic variation in soluble epoxide hydrolase: association with outcome after aneurysmal subarachnoid hemorrhage.

Authors:  Ross P Martini; Jonathan Ward; Dominic A Siler; Jamie M Eastman; Jonathan W Nelson; Rohan N Borkar; Nabil J Alkayed; Aclan Dogan; Justin S Cetas
Journal:  J Neurosurg       Date:  2014-09-12       Impact factor: 5.115

10.  Preventive Antibiotics and Delayed Cerebral Ischaemia in Patients with Aneurysmal Subarachnoid Haemorrhage Admitted to the Intensive Care Unit.

Authors:  Celine S Gathier; Evelien A Oostdijk; Gabriel J E Rinkel; Sanne M Dorhout Mees; Mervyn D I Vergouwen; Anne Marie G A de Smet; Diederik van de Beek; W Peter Vandertop; Dagmar Verbaan; Ale Algra; Marc J M Bonten; Walter M van den Bergh
Journal:  Neurocrit Care       Date:  2016-02       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.